Indeed, EGF expression correlated with NRF2 activation in different cancer types, as we showed for NFE2L2/KEAP1 mutant lung adenocarcinoma as well as head and neck squamous cell carcinoma. Here, KEAP1 is linked to lung adenocarcinoma.